TAFFA N TMUSNIWIN TUSNANIN

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping

World Health OrganizationTasleḍt n yimsɣan2026Asuffeɣ unṣib

Agzul n yisemli ASEM

Official World Health Organization document (2026) on “WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping”. This guideline presents evidence-based recommendations from the World Health Organization on the use of human papillomavirus (HPV) DNA genotyping in screening programmes for the prevention of cervical pre-cancer and cancer.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib